Development of Organelle Replacement Therapy Using a Stearyl-Polyhistidine Peptide against Lysosomal Storage Disease Cells

We previously reported on a polyhistidine peptide, His16 peptide, as a new cell-penetrating peptide. This peptide is anticipated to be a new carrier for drug delivery systems (DDSs) for targeting intracellular lysosomes because it can transport macromolecules (e.g., liposomes) into these organelles....

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Taiki, Okamoto, Riku, Kawano, Tsuyoshi, Iwasaki, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720886/
https://www.ncbi.nlm.nih.gov/pubmed/31426598
http://dx.doi.org/10.3390/molecules24162995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720886/
https://www.ncbi.nlm.nih.gov/pubmed/31426598
http://dx.doi.org/10.3390/molecules24162995

Ejemplares similares